Xiaoyang Luo
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 18
- Lung Cancer Diagnosis and Treatment 13
- Gastric Cancer Management and Outcomes 4
- Oncology 20
- Lung Cancer Research Studies 8
- HER2/EGFR in Cancer Research 3
- Co-authors
- Haiquan Chen (20 shared papers)Haichuan Hu (17 shared papers)Yunjian Pan (15 shared papers)Yihua Sun (17 shared papers)Yuan Li (16 shared papers)Ting Ye (16 shared papers)Hang Li (14 shared papers)Lei Shen (16 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Journal of Thoracic Oncology (3 papers)Lung Cancer (3 papers)OncoTargets and Therapy (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Xiaoyang Luo
46 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 107
- Pulmonary and Respiratory Medicine 1.7k
- Oncology 1.2k
- Cancer Research 581
- Microbiology 12
- Molecular Biology 881
Countries citing papers authored by Xiaoyang Luo
This map shows the geographic impact of Xiaoyang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Luo more than expected).
Fields of papers citing papers by Xiaoyang Luo
This network shows the impact of papers produced by Xiaoyang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Luo. The network helps show where Xiaoyang Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoyang Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 413 | |
| 2 | 2014 | 192 | |
| 3 | 2014 | 180 | |
| 4 | 2012 | 151 | |
| 5 | 2011 | 146 | |
| 6 | 2014 | 116 | |
| 7 | 2011 | 116 | |
| 8 | 2010 | 113 | |
| 9 | 2011 | 93 | |
| 10 | 2011 | 76 | |
| 11 | 2012 | 75 | |
| 12 | 2014 | 72 | |
| 13 | 2010 | 72 | |
| 14 | 2013 | 65 | |
| 15 | 2015 | 63 | |
| 16 | 2012 | 59 | |
| 17 | 2015 | 58 | |
| 18 | Inhibition of BACE1 for therapeutic use in Alzheimer's disease. | 2010 | 53 |
| 19 | 2011 | 51 | |
| 20 | 2014 | 46 |
About Xiaoyang Luo
Xiaoyang Luo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 46 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Research Studies (8 papers), Cancer Genomics and Diagnostics (6 papers), RNA modifications and cancer (5 papers), Esophageal Cancer Research and Treatment (4 papers), Gastric Cancer Management and Outcomes (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Oncology (1.2k citations), Cancer Research (581 citations), Microbiology (12 citations) and Molecular Biology (881 citations). Xiaoyang Luo has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Haiquan Chen, Haichuan Hu, Yunjian Pan, Yihua Sun, Yuan Li, Ting Ye, Hang Li, Lei Shen, Yang Zhang and Rui Wang. Their work appears in journals such as Clinical Cancer Research, Journal of Thoracic Oncology, Lung Cancer, OncoTargets and Therapy and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.